Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial.
Kytölä S, Vänttinen I, Ruokoranta T, Partanen A, Holopainen A, Saad J, Kuusisto MEL, Koskela S, Räty R, Itälä-Remes M, Västrik I, Suvela M, Parsons A, Porkka K, Wennerberg K, Heckman CA, Jalkanen T, Huttunen T, Ettala P, Rimpiläinen J, Siitonen T, Pyörälä M, Kuusanmäki H, Kontro M. Kytölä S, et al. Among authors: huttunen t. Blood. 2025 Jan 23;145(4):409-421. doi: 10.1182/blood.2024024968. Blood. 2025. PMID: 39357056 Free article. Clinical Trial.
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
Joensuu H, Fraser J, Wildiers H, Huovinen R, Auvinen P, Utriainen M, Villman KK, Halonen P, Granstam-Björneklett H, Tanner M, Sailas L, Turpeenniemi-Hujanen T, Yachnin J, Huttunen T, Neven P, Canney P, Harvey VJ, Kellokumpu-Lehtinen PL, Lindman H. Joensuu H, et al. Among authors: huttunen t. JAMA Netw Open. 2024 Aug 1;7(8):e2429772. doi: 10.1001/jamanetworkopen.2024.29772. JAMA Netw Open. 2024. PMID: 39186271 Free PMC article. Clinical Trial.
Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson's disease.
Liikkanen S, Sinkkonen J, Suorsa J, Kaasinen V, Pekkonen E, Kärppä M, Scheperjans F, Huttunen T, Sarapohja T, Pesonen U, Kuoppamäki M, Keränen T. Liikkanen S, et al. Among authors: huttunen t. PLOS Digit Health. 2023 Apr 7;2(4):e0000225. doi: 10.1371/journal.pdig.0000225. eCollection 2023 Apr. PLOS Digit Health. 2023. PMID: 37027348 Free PMC article.
Adjuvant Docetaxel Versus Surveillance in Intermediate- or High-risk Prostate Cancer After Radical Curative Radiotherapy: Final Survival Results from the SPCG-13 Trial.
Kellokumpu-Lehtinen PL, Fransson AS, Marttila T, Lehtinen I, Huttunen T, Thellenberg-Karlsson C; SPCG-13 Investigators. Kellokumpu-Lehtinen PL, et al. Among authors: huttunen t. Eur Urol Oncol. 2025 Aug;8(4):999-1002. doi: 10.1016/j.euo.2025.04.013. Epub 2025 Apr 30. Eur Urol Oncol. 2025. PMID: 40312180 Free article. Clinical Trial.
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data.
Earl HM, Hiller L, Dunn JA, Patel M, Conte P, D'Amico R, Guarneri V, Joensuu H, Huttunen T, Hatzidaki D, Georgoulias V, Abraham JE, Miles D, Cameron DA, Wardley AM, Pivot X. Earl HM, et al. Among authors: huttunen t. BMJ Oncol. 2025 Jun 20;4(1):e000810. doi: 10.1136/bmjonc-2025-000810. eCollection 2025. BMJ Oncol. 2025. PMID: 40552247 Free PMC article.
132 results